Continued epidemiologic analysis of large NF2 patient populations as well as the increasing availability of molecular data should result in further clarification of diagnostic criteria, particularly regarding delineation of related but separate syndromes such as schwannomatosis and the identification of NF2 patients with mosaic phenotypes, which remains challenging. Here, NF2 is linked to schwannomatosis.